Abstract:Yongwei Gu, 1– 3, * Qing Gu, 4, * Qing Yang, 1, 2 Meng Yang, 3 Shengzhang Wang, 5 Jiyong Liu 1– 3 1 Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, People's Republic of China; 2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China; 3 Department of Pharmacy, Changhai Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China; 4 Department of Pharmacy, Jingan District Zhabei Central Hospital, Shanghai 200070, People's Republic of China; 5 Institute of Biomechanics, Department of Aeronautics and Astronautics, Fudan University, Shanghai 200433, People's Republic of China *These authors contributed equally to this work Correspondence: Shengzhang Wang Department of Aeronautics and Astronautics, Institute of Biomechanics, Fudan University, Shanghai 200433, People's Republic of China Tel/Fax +86-21-65647825 Email szwang@fudan.edu.cn Jiyong Liu Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, People's Republic of China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China Tel/Fax +86-21-64175590 Email liujiyong@fudan.edu.cn Background: Skin pharmacokinetics is an indispensable indication for studying the drug fate after administration of transdermal drug delivery systems (TDDS). However, the heterogeneity and complex skin structured with stratum corneum, viable epidermis, dermis, and subcutaneous tissue inevitably leads the drug diffusion coefficient ( K p) to vary depending on the skin depth, which seriously limits the development of TDDS pharmacokinetics in full thickness skin. Methods: A multilayer geometry skin model was established and the K p of drug in SC, viable epidermis, and dermis was obtained using the technologies of molecular dynamics simulation, in vitro permeation experiments, and in vivo microdialysis, respectively. Besides, finite element analysis (FEA) based on drug K ps in different skin layers was applied to simulate the paeonol nanoemulsion (PAE-NEs) percutaneous dynamic penetration process in two and three dimensions. In addition, PAE-NEs skin pharmacokinetics profile obtained by the simulation was verified by in vivo experiment. Results: Coarse-grained modeling of molecular dynamic simulation was successfully established and the K p of PAE in SC was 2.00× 10 − 6 cm 2 /h. The K p of PAE-NE in viable epidermis and in dermis detected using penetration test and microdialysis probe technology, was 1.58× 10 − 5 cm 2 /h and 3.20× 10 − 5 cm 2 /h, respectively. In addition, the results of verification indicated that PAE-NEs skin pharmacokinetics profile obtained by the simulation was consistent with that by in vivo experiment. Discussion: This study demonstrated that the FEA combined with the established multilayer geometry skin model could accurately predict the skin pharmacokinetics of TDDS. Keywords: nano transdermal drug delivery system, skin pharmacokinetics, finite element analysis, multilayer geometry model, diffusion coefficient, paeonol nanoemulsion

In Silico Prediction of Percutaneous Absorption and Disposition Kinetics of Chemicals

Modeling Transdermal Permeation. Part I. Predicting Skin Permeability of Both Hydrophobic and Hydrophilic Solutes

Modeling Transdermal Permeation. Part 2. Predicting the Dermatopharmacokinetics of Percutaneous Solute

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

Quantum-Mechanics Calculations Elucidate Skin-Sensitizing Pharmaceutical Compounds

PREDICTING SKIN PERMEABILITY OF DRUGS WITH THEORETICAL PARAMETERS

Recent advances in predicting skin permeability of hydrophilic solutes.

Use of “bricks and Mortar” Model to Predict Transdermal Permeation: Model Development and Initial Validation

An evaluation of mathematical models for predicting skin permeability.

An Investigation into the Transdermal Behavior of Active Ingredients by Combination of Experiments and Multiscale Simulations

Finite Element Analysis for Predicting Skin Pharmacokinetics of Nano Transdermal Drug Delivery System Based on the Multilayer Geometry Model

Percutaneous absorption of steroids from finite doses: Predicting urinary excretion from in vitro skin permeation testing

A Data-Mining Approach for the Quantitative Assessment of Physicochemical Properties of Molecular Compounds in the Skin Flux

Multi‐phase Multi‐Layer Mechanistic Dermal Absorption (MPML MechDermA) Model to predict local and systemic exposure of drug products applied on skin

Predicting Human Dermal Drug Concentrations Using PBPK Modeling and Simulation: Clobetasol Propionate Case Study

Predictive modeling of skin permeability for molecules: Investigating FDA-approved drug permeability with various AI algorithms

Prediction of the Skin Sensitising Potential and Potency of Compounds Via Mechanism-Based Binary and Ternary Classification Models.

New trends in mechanistic transdermal drug delivery modelling: Towards an accurate description of skin microstructure

Penetration pathways, influencing factors and predictive models for dermal absorption of exobiotic molecules: A critical review

Modeling the percutaneous absorption of solvent-deposited solids over a wide dose range: II. Weak electrolytes

Impact of solvent dry down, phase change, vehicle pH and slowly reversible keratin binding on skin penetration of cosmetic relevant compounds: II. Solids